|
1
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang HF and Yang LL: Gamma-Mangostin, a
micronutrient of mangosteen fruit, induces apoptosis in human colon
cancer cells. Molecules. 17:8010–8021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu T, Li D and Jiang D: Targeting cell
signaling and apoptotic pathways by luteolin: Cardioprotective role
in rat cardiomyocytes following ischemia/reperfusion. Nutrients.
4:2008–2019. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim DY, Jeong Y, Tyner AL and Park JH:
Induction of cell cycle arrest and apoptosis in HT-29 human colon
cancer cells by the dietary compound luteolin. Am J Physiol
Gastrointest Liver Physiol. 292:G66–G75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xavier CP, Lima CF, Preto A, Seruca R,
Fernandes-Ferreira M and Pereira-Wilson C: Luteolin, quercetin and
ursolic acid are potent inhibitors of proliferation and inducers of
apoptosis in both KRAS and BRAF mutated human colorectal cancer
cells. Cancer Lett. 281:162–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seelinger G, Merfort I, Wölfle U and
Schempp CM: Anti-carcinogenic effects of the flavonoid luteolin.
Molecules. 13:2628–2651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu H, Gao F, Shu G, Xia G, Shao Z, Lu H
and Cheng K: Wogonin inhibits the proliferation of myelodysplastic
syndrome cells through the induction of cell cycle arrest and
apoptosis. Mol Med Rep. 12:7285–7292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pandurangan AK, Dharmalingam P, Sadagopan
SK, Ramar M, Munusamy A and Ganapasam S: Luteolin induces growth
arrest in colon cancer cells through involvement of
Wnt/β-catenin/GSK-3β signaling. J Environ Pathol Toxicol Oncol.
32:131–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suh Y, Afaq F, Johnson JJ and Mukhtar H: A
plant flavonoid fisetin induces apoptosis in colon cancer cells by
inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways.
Carcinogenesis. 30:300–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turktekin M, Konac E, Onen HI, Alp E,
Yilmaz A and Menevse S: Evaluation of the effects of the flavonoid
apigenin on apoptotic pathway gene expression on the colon cancer
cell line (HT29). J Med Food. 14:1107–1117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Gong Y, Li L, Abdolmaleky HM and
Zhou JR: Bioactive tanshinone I inhibits the growth of lung cancer
in part via downregulation of aurora a function. Mol Carcinog.
52:535–543. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sulaiman GM: In vitro study of molecular
structure and cytotoxicity effect of luteolin in the human colon
carcinoma cells. Eur Food Res Technol. 241:83–90. 2015. View Article : Google Scholar
|
|
13
|
Horinaka M, Yoshida T, Shiraishi T, Nakata
S, Wakada M, Nakanishi R, Nishino H, Matsui H and Sakai T: Luteolin
induces apoptosis via death receptor 5 upregulation in human
malignant tumor cells. Oncogene. 24:7180–7189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai X, Ye T, Liu C, Lu W, Lu M, Zhang J,
Wang M and Cao P: Luteolin induced G2 phase cell cycle arrest and
apoptosis on non-small cell lung cancer cells. Toxicol In Vitro.
25:1385–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krasinska L, Cot E and Fisher D: Selective
chemical inhibition as a tool to study Cdk1 and Cdk2 functions in
the cell cycle. Cell Cycle. 7:1702–1708. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Canavese M, Santo L and Raje N: Cyclin
dependent kinases in cancer: Potential for therapeutic
intervention. Cancer Biol Ther. 13:451–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nigg EA: Cyclin-dependent protein kinases:
Key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou M, Li Y, Hu Q, Bai XC, Huang W, Yan
C, Scheres SH and Shi Y: Atomic structure of the apoptosome:
Mechanism of cytochrome c- and dATP-mediated activation of Apaf-1.
Genes Dev. 29:2349–2361. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun KW, Ma YY, Guan TP, Xia YJ, Shao CM,
Chen LG, Ren YJ, Yao HB, Yang Q and He XJ: Oridonin induces
apoptosis in gastric cancer through Apaf-1, cytochrome c and
caspase-3 signaling pathway. World J Gastroenterol. 18:7166–7174.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bagli E, Stefaniotou M, Morbidelli L,
Ziche M, Psillas K, Murphy C and Fotsis T: Luteolin inhibits
vascular endothelial growth factor-induced angiogenesis; inhibition
of endothelial cell survival and proliferation by targeting
phosphatidylinositol 3′-kinase activity. Cancer Res. 64:7936–7946.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ueda H, Yamazaki C and Yamazaki M:
Inhibitory effect of perilla leaf extract and luteolin on mouse
skin tumor promotion. Biol Pharm Bull. 26:560–563. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiu FL and Lin JK: Downregulation of
androgen receptor expression by luteolin causes inhibition of cell
proliferation and induction of apoptosis in human prostate cancer
cells and xenografts. Prostate. 68:61–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin Y, Shi RX, Wang X and Shen HM:
Luteolin, a flavonoid with potential for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
